Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
A strategic buyer has acquired a medical devices business in Alpharetta, Georgia, for $1.3B. The target develops and manufactures medical devices used in healthcare settings, supporting clinical workflows and patient care. The acquisition expands the buyer’s healthcare M&A footprint in GA acquisitions and strengthens its portfolio in the medical devices sub-sector. The deal is announced and valued at over $100M, reflecting a platform-style expansion by a strategic acquirer rather than a small add-on. Healthcare deals GA are driven by product breadth, manufacturing scale, and the ability to accelerate growth across medical device categories.
Source
Read full article on pressreader.comvia GN - medical device equipment acquired · April 15, 2026
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026